Standout Papers

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failu... 2020 2026 2022 2024219
  1. Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure (2020)
    Jordan Gauthier, Alexandre V. Hirayama et al. Blood

Immediate Impact

1 by Nobel laureates 7 from Science/Nature 59 standout
Sub-graph 1 of 23

Citing Papers

Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
Past, present, and future of CRISPR genome editing technologies
2024 Standout
2 intermediate papers

Works of Alyssa Sheih being referenced

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure
2020 Standout
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
2020

Author Peers

Author Last Decade Papers Cites
Alyssa Sheih 425 228 211 21 674
Kathleen Gallagher 575 181 189 30 762
Sunil S. Raikar 388 235 194 36 600
Frederic B. Thalheimer 464 187 366 23 700
Shimobi Onuoha 441 174 243 28 696
Susanne Hofmann 448 276 297 36 731
Semjon Willier 407 172 334 21 687
Tatsunori Goto 422 236 211 47 701
Alexander Jares 488 389 237 10 701
Greta Maria Paola Giordano Attianese 547 351 214 20 731
Sebastian Newrzela 477 254 355 29 832

All Works

Loading papers...

Rankless by CCL
2026